GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » MetLife Inc (BSP:METB34) » Definitions » Research & Development

MetLife (BSP:METB34) Research & Development : R$0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is MetLife Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. MetLife's Research & Development for the three months ended in Mar. 2024 was R$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was R$0 Mil.


MetLife Research & Development Historical Data

The historical data trend for MetLife's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MetLife Research & Development Chart

MetLife Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MetLife Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MetLife Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MetLife  (BSP:METB34) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


MetLife Research & Development Related Terms

Thank you for viewing the detailed overview of MetLife's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


MetLife (BSP:METB34) Business Description

Address
200 Park Avenue, New York, NY, USA, 10166-0188
MetLife is one of the largest life insurers in the U.S. by assets and provides a variety of insurance and financial services products. The company is organized into five segments: U.S., Asia, Latin America, EMEA, and MetLife Holdings. The U.S. business contributes around 41% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 28% of earnings and is mainly composed of the Japan business with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile with the Latin America segment contributing around 6% of earnings. The EMEA and the MetLife segments contribute around 5% and 20% of earnings, respectively.

MetLife (BSP:METB34) Headlines

No Headlines